Director/PDMR Shareholding

RNS Number : 1728F

GlaxoSmithKline PLC

17 February 2015

 

Notification of Transactions of Directors and Persons Discharging Managerial   Responsibility

GlaxoSmithKline Performance Share Plan

Sale of shares to meet tax liabilities

The table below sets out changes in the interests of Directors and Persons Discharging Managerial Responsibility (PDMR) in the Ordinary Shares of GlaxoSmithKline plc arising from the sale of Ordinary Shares at a fair market value price of £15.4312 per Ordinary Share on 13 February 2015 to meet tax liabilities following the vesting of awards granted under the GlaxoSmithKline 2009 Performance Share Plan (PSP).

	Number of Ordinary Shares sold to meet tax liabilities following the vesting of a PSP award
Sir Andrew Witty*	24,552
Mr S Dingemans*	12,605
Mr A Hussain	8,238
Mr D Redfern	4,723
Ms C Thomas	6,191
Mr P Thomson	3,149
Dr P Vallance	12,067
Ms E Walmsley	7,136

* Denotes an Executive Director

The table below sets out changes in the interests of PDMRs in the American Depositary Shares (ADS) of GlaxoSmithKline plc arising from the withholding of ADSs at a closing share price  of $46.21 per ADS on 11 February 2015 to establish the fair market value to meet tax liabilities following the vesting of awards granted under the PSP.

	Number of ADSs withheld to meet tax liabilities following the vesting of a PSP award
Mr W Louv	2,892
Mr D Troy	3,966

The Company, Directors and PDMRs were advised of these transactions on 17 February 2015.

This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

V A Whyte

Company Secretary

17 February 2015

 

END

 

 

RDSDDLFFELFXBBV